Pubblicazioni

Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis

2024 - CURRENT NEUROPHARMACOLOGY

Dolcetti, Ettore; Annovazzi, Pietro; Clerico, Marinella; Cocco, Eleonora; Conte, Antonella; Marfia, Girolama Alessandra; Salvetti, Marco; Tomassini, Valentina; Clerici, Valentina Torri; Totaro, Rocco; Bruno, Antonio; Centonze, Diego

Disease-modifying symptomatic treatment (DMST) potential of cannabinoids in patients with multiple sclerosis

2024 - CURRENT NEUROPHARMACOLOGY

Bruno, Antonio; Annovazzi, Pietro; Clerico, Marinella; Cocco, Eleonora; Conte, Antonella; Marfia, Girolama Alessandra; Salvetti, Marco; Torri Clerici, Valentina; Cleric, Valentina Torri; Totaro, Rocco; Dolcetti, Ettore; Centonze, Diego

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets

2022 - CURRENT NEUROPHARMACOLOGY

Moiola, Lucia; Riva, Agostino; Nicoletti, Ferdinando; Uccelli, Antonio; Salvetti, Marco; Battistini, Luca; Furlan, Roberto

Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint

2021 - CURRENT NEUROPHARMACOLOGY

Alborghetti, Marika; Bellucci, Gianmarco; Gentile, Antonietta; Calderoni, Chiara; Nicoletti, Ferdinando; Capra, Ruggero; Salvetti, Marco; Centonze, Diego